Impact of immunomodulatory oligodeoxynucleotides on cytokine production in the lipopolysaccharide-stimulated human whole blood model
- 31 August 2004
- Vol. 136 (2) , 464-472
- https://doi.org/10.1016/j.surg.2004.05.026
Abstract
No abstract availableKeywords
This publication has 20 references indexed in Scilit:
- Blood plasmacytoid dendritic cell responses to CpG oligodeoxynucleotides are impaired in human newbornsBlood, 2004
- Regulation of CpG‐Induced Immune Activation by Suppressive OligodeoxynucleotidesAnnals of the New York Academy of Sciences, 2003
- Toll-like receptors: balancing host resistance with immune toleranceCurrent Opinion in Immunology, 2003
- Inhibition of Neutrophil Apoptosis by Type 1 IFN Depends on Cross-Talk Between Phosphoinositol 3-Kinase, Protein Kinase C-δ, and NF-κB Signaling PathwaysThe Journal of Immunology, 2003
- Identification of CpG oligonucleotide sequences with high induction of IFN-α/β in plasmacytoid dendritic cellsEuropean Journal of Immunology, 2001
- Preexposure of Murine Macrophages to CpG Oligonucleotide Results in a Biphasic Tumor Necrosis Factor Alpha Response to Subsequent Lipopolysaccharide ChallengeInfection and Immunity, 2001
- Efficacy and Safety of Recombinant Human Activated Protein C for Severe SepsisNew England Journal of Medicine, 2001
- Antisense therapeutics: is it as simple as complementary base recognition?Molecular Medicine Today, 2000
- DNA activates human immune cells through a CpG sequence‐dependent mannerImmunology, 1999
- The Natural History of the Systemic Inflammatory Response Syndrome (SIRS)JAMA, 1995